Twist Bioscience Corporation
TWST
Rangering i aksjer
#2145
Twist Bioscience Corporation operates as a leading synthetic biology firm,... Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
Aksjekurs
$144.87
Sist synkronisert: 2026-10-20
Markedsverdi
$9.54B
Endring (1 dag)
3.65%
Endring (1 år)
333.86%
Land
US
Handel Twist Bioscience Corporation (TWST)
Kategori
Healthcare
Antall utestående aksjer for Twist Bioscience Corporation (TWST)
Antall utestående aksjer per June 2026: 62.40M
Ifølge Twist Bioscience Corporation sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 62.40M. Ved slutten av September 2024 hadde selskapet 58.02M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Twist Bioscience Corporation (TWST) fra 2016 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 62.40M | 4.34% |
| 2025 | 59.81M | 3.09% |
| 2024 | 58.02M | 1.99% |
| 2023 | 56.89M | 5.57% |
| 2022 | 53.89M | 11.68% |
| 2021 | 48.25M | 23.12% |
| 2020 | 39.19M | 42.71% |
| 2019 | 27.46M | 3.20% |
| 2018 | 26.61M | 41.69% |
| 2017 | 18.78M | 0.00% |
| 2016 | 18.78M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 371.00M | 494.52% |
US
|
|
| 705.30M | 1,030.23% |
US
|
|
| 143.28M | 129.60% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 351.90% |
US
|
